Brimonidine / brinzolamide ophthalmic Pregnancy and Breastfeeding Warnings
Brimonidine / brinzolamide ophthalmic is also known as: Simbrinza
Brimonidine / brinzolamide ophthalmic Pregnancy Warnings
Maternal and developmental toxicity was observed in animals with brinzolamide at oral doses of 20 to 120 times the recommended human ophthalmic dose. No fetal harm was seen in animal studies with oral doses of brimonidine reaching plasma concentrations 100 times higher than that seen in humans at recommended human ophthalmic dose. Brimonidine crossed the placenta and a small amount entered the fetal circulation in animals. There are no controlled data in human pregnancy. FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
FDA pregnancy category: C Potential benefit should outweigh the potential risk.
Brimonidine / brinzolamide ophthalmic Breastfeeding Warnings
A decision should be made to discontinue breast-feeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown (brinzolamide/brimonidine) Excreted into animal milk: Yes (brinzolamide/brimonidine) The effects in the nursing infant are unknown.
- brinzolamide/brimonidine drops Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.